Adcentrx Therapeutics, Inc.
Overview
Adcentrx Therapeutics, Inc. is a biotechnology company that focuses on developing innovative antibodies for diverse therapeutic areas. The company is committed to advancing next-generation immune-conjugates to treat complex diseases.
Therapeutic areas
API / Drug Master Files
Adcentrx Therapeutics, Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- AMTX-100 CF3 CMCActive2023-03-09
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Adcentrx Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.